Net sales Cost of goods sold Gross profit Fixed operating costs except depreciation Depreciation Earnings before interest and taxes Interest Earnings before taxes Taxes Net income Common dividends Addition to retained earnings Earnings per share Dividends per share Number of common shares (millions) This Year's Actual Results $19,000,000 15,200,000 $3,800,000 950,000 380,000 $2,470,000 380,000 $2,090,000 836,000 $1,254,000 677,160 $576,840 $0.25 Next Year's Initial Forecast $22,420,000 17,936,000 $4,484,000 950,000 448,400 $2,914,600 380,000 $2,534,600 1,013,840 $1,520,760 677,160 $843,600 $0.30 $0.14 $0.14 5.00 5.00 Which of the following are assumptions made by the initial income statement forecast? Check all that apply. Blue Lemon Pharmaceutical Company will be issuing additional shares of common stock in the coming year. The cost of sales percentage for Blue Lemon Pharmaceutical Company will decrease due to economies of scale. Spontaneously generated funds will sufficiently cover any financing needs. The forecasted increase in net sales is 18.00%. No excess capacity currently exists